Very low-density lipoprotein-apoprotein CI is increased in diabetic nephropathy: Comparison with apoprotein CIII

Kidney International

Volumn 63, Issue 6, 2003, Pages 2171-2177

  Hirano, Tsutomu ^a   Sakaue, Taro ^b   Misaki, Asako ^b   Murayama, Satoru ^b   Takahashi, Toshihiro ^b   Okada, Kenta ^b   Takeuchi, Hiroko ^b   Yoshino, Gen ^b   Adachi, Mitsuru ^b  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Apoprotein CI; Apoprotein CIII; Chronic renal failure; Diabetic nephropathy; VLDL

Indexed keywords

ALBUMIN; APOLIPOPROTEIN B; APOPROTEIN; APOPROTEIN CIII; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN APOPROTEIN CI;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONCENTRATION PROCESS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTRIGLYCERIDEMIA; INCIDENCE; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEINURIA; RISK FACTOR; SEPARATION TECHNIQUE; ULTRACENTRIFUGATION;

EID: 0037850912     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00019.x     Document Type: Article

References (25)

1. UNITED STATES RENAL DATA SYSTEM: USRDS 1998 Annual Data Report, Excerpts from V and VI. Am J Kidney Dis 32(Suppl 1): S69-S88, 1998
2. HAHN R, OETTE K, MONDORF H, et al: Analysis of cardiovascular risk factors in chronic hemodialysis patients with special attention to the hyperlipoproteinemias. Atherosclerosis 48:279-288, 1983
3. CHEUNG AK, SARNAK MJ, YAN G, et al: Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 58:353-362, 2000
4. VALMADRID CT, KLEIN R, MOSS SE, et al: The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med 160:1093-1100, 2000
5. ATTMAN P-O, KNIGHT-GIBSON C, TAVELLA M, et al: The compositional abnormalities of lipoproteins in diabetic renal failure. Nephrol Dial Transplant 13:2833-2841, 1998
6. HIRANO T: Lipoprotein abnormalities in diabetic nephropathy. Kidney Int 71:S22-24, 1999
7. JENSEN T, BORCH-JOHNSEN K, KOFOED-ENEVOLDSEN A, et al: Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: Incidence and risk factors. Diabetologia 30:144-148, 1987
8. DE COSMO S, BACCI S, PIRAS GP, et al: High prevalence of risk factors for cardiovascular disease in parents of IDDM patients with albuminuria. Diabetologia 40:1191-1196, 1997
9. KASHIWAZAKI K, HIRANO T, YOSHINO G, et al: Decreased release of lipoprotein lipase is associated with vascular endothelial damage in NIDDM patients with microalbuminuria. Diabetes Care 21:2016-2020, 1998
10. HIRANO T, OI K, SAKAI S, et al: High prevalence of small dense LDL in diabetic nephropathy is not directly associated with kidney damage: A possible role of postprandial lipemia. Atherosclerosis 141:77-85, 1998
11. HIRANO T, SAKAUE T, KOBA S: Increased VLDL particle number is a leading cause for coronary heart disease independent of IDL or dense LDL in Japanese men. Circulation 102(Suppl II):506, 2000
12. WINDLER E, HAVEL RJ: Inhibitory effects of C apoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and remnants by the perfused rat liver. J Lipid Res 26:556-565, 1985
13. SHACHTER NS, EBARA T. RAMAKRISHNAN R, STEINER G, et al: Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein Cl. J Clin Invest 98:846-855, 1996
14. JONG MC, DAHLMANS VE, VAN GORP PJ, et al: In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway. J Clin Invest 98:2259-2267, 1996
15. SAKAUE T, HIRANO T, YOSHINO G, et al: The influence of diabetic nephropathy on remnant lipoproteins. J Japan Diab Soc 42:439-446, 1999
16. HIRANO T, OI K, SAKI S, et al: High prevalence of small dense LDL in diabetic nephropathy is not directly associated with kidney damage: A possible role of postprandial lipemia. Atherosclerosis 141:77-85, 1998
17. SAKAUE T, HIRANO T, YOSHINO G, et al: Reactions of direct LDL-cholesterol assays with pure LDL fraction and IDL: Comparison of three homogeneous methods. Clin Chim Acta 295:97-106, 2000
18. YOUNG SG, SMITH RS, HOGLE DM, et al: Two new monoclonal antibody-based enzyme-linked assays of apolipoprotein B. Clin Chem 32:1484-1490, 1986
19. BJORKEGREN J, BOQUIST S, SAMNEGARD A, et al: Accumulation of apolipoprotein C-I-rich and cholesterol-rich VLDL remnants during exaggerated postprandial triglyceridemia in normolipidemic patients with coronary artery disease. Circulation 101:227-230, 2000
20. STEINER G, SCHWARTZ L, SHUMAK S. et al: The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease. Circulation 75:124-130, 1987
21. TKAC I, KIMBALL BP, LEWIS G, et al: The severity of coronary atherosclerosis in type 2 diabetes mellitus is related to the number of circulating triglyceride-rich lipoprotein particles. Arterioscler Thromb Vasc Biol 17:3633-3638, 1997
22. SACKS FM, ALAUPOVIC P, MOYE LA, et al: VLDL, apolipoproteins B, CIII, and E. and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial. Circulation 102:1886-1892, 2000
23. HIRANO T, SAKAUE T, KOBA S: Increased VLDL partice number is a leading cause for coronary heart disease independent of IDL or dense LDL in Japanese men. Circulation 102(Suppl II):506, 2000
24. SHACHTER NS: Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism. Curr Opin Lipidol 12:297-304, 2001
25. ATTMAN P-O, ALAUPOVIC P, TAVELLA A, et al: Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure. Nephrol Dial Transplant 11:63-69, 1996